Concepedia

Yanmei Hu

YH

61

Publications

4.5K

Citations

32

H-Index

2013

Active since

Affiliations

University of Arizona(Current)

University of South Florida

Rutgers, The State University of New Jersey

National and Kapodistrian University of Athens

Utah State University

Yanmei Hu is an author at University of Arizona specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

2013–2024

61

Publications

61

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

Chunlong Ma, M. Sacco, Brett L. Hurst et al. · Cell Research · 2020 · 870 citations · Full text

Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M <sup>pro</sup> and cathepsin L

M. Sacco, Chunlong Ma, Panagiotis Lagarias et al. · Science Advances · 2020 · 390 citations · Full text

Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir

Yanmei Hu, Eric M. Lewandowski, Haozhou Tan et al. · ACS Central Science · 2023 · 288 citations · Full text

Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors

Chunlong Ma, Yanmei Hu, Julia A. Townsend et al. · ACS Pharmacology & Translational Science · 2020 · 264 citations · Full text

Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay

Chunlong Ma, M. Sacco, Zilei Xia et al. · ACS Central Science · 2021 · 191 citations · Full text

Rows per page

1–5 of 61